Navigation Links
EyeCare 20/20 is First Ophthalmology Practice in New Jersey to Offer Precision Laser Cataract Surgery with Catalys
Date:2/19/2013

East Hanover, NJ (PRWEB) February 19, 2013

EyeCare 20/20 has become the first ophthalmology practice in New Jersey to offer cataract surgery with the Catalys® Precision Laser System. Catalys combines a state-of-the-art femtosecond laser, advanced 3D Optical Coherence Tomography (OCT) imaging, sophisticated software and a host of other unique features that enable surgeons to provide patients a gentle, highly customized procedure with unprecedented precision.

“At EyeCare 20/20, we pride ourselves on our ability to meet patient needs in unique and innovative ways. The Catalys Precision Laser System will allow our patient family to continue to receive the best eye care procedure available,” said Medical Director Cary Silverman, M.D., M.B.A.

A cataract is a common condition in which the lens of the eye becomes progressively cloudy, making vision fuzzy and normal daily living activities more difficult. Cataract surgery is the only treatment for cataracts and is one of the most widely performed procedures worldwide, estimated at 19 million cases per year.1 In the traditional (non-laser) approach, the surgeon must perform several critical steps using handheld instruments. This manual approach limits predictability and precision, potentially affecting visual outcomes and complication rates. In recent years, femtosecond laser and 3D imaging technology have been incorporated into cataract surgery to enhance the precision, accuracy and customization of the procedure. The Catalys Precision Laser System represents the new standard in the field and has been shown in clinical study to deliver precision that is unequaled in the industry. (2,3)

Using Catalys, surgeons can access and remove the cataract with accuracy that is approximately 10 times greater than that achieved with manual technique . (2,3) This precision and accuracy sets the stage for the proper positioning of the artificial replacement lens. In addition, Catalys’ sophisticated laser technology makes break-up and removal of the cataract easier and gentler on the patient.(4) A clinical study has shown that Catalys can nearly or completely eliminates the ultrasound energy traditionally needed during this step. This low-energy approach reduces inflammation, with more rapid recovery expected. (4,5)

Depending on the patient’s pre-operative vision and desired visual result, EyeCare 20/20 may recommend a tailored treatment plan that could include creating ultra-precise laser incisions in the cornea and a specific lens type, such as a multi-focal lens for near and far vision. This tailored treatment may reduce the need for glasses or contacts after surgery.

Laser treatment with Catalys takes approximately three minutes and causes little or no discomfort to patients.

The Catalys Precision Laser System was developed by OptiMedica® Corp. (Sunnyvale, Calif., USA) in close collaboration with a Medical Advisory Board of cataract experts from around the world. Catalys was CE mark approved in August 2011 and market cleared by the U.S. Food and Drug Administration in December 2011. The system is available at leading ophthalmology practices around the world.

For more information regarding precision laser cataract surgery with Catalys at EyeCare 20/20, please call 973-664-7794 or visit http://www.eyecare2020.com

About OptiMedica
OptiMedica Corp. is a Silicon Valley-based global ophthalmic device company dedicated to developing performance-driven technologies that improve patient outcomes. Exclusively focused in the cataract therapeutic area, the company has developed the Catalys Precision Laser System to deliver unparalleled precision in cataract surgery. For more information, please visit http://www.optimedica.com.

About EyeCare 20/20
EyeCare 20/20 has served patients in East Hanover and throughout northern New Jersey since 1986. In addition to LASIK services, EyeCare 20/20 also provides: cataract, Phakic Lenses, Near Vision CK, Corneal Transplants, LACL, EPI-LASIK, and LASEK. For more information, contact EyeCare 20/20 online at http://www.eyecare2020.com or call 973.664.7794.

References
(1) 2011 Market Scope Report on the Global Cataract Equipment Market
(2 ) Friedman, NJ, et al., “Femtosecond Laser Capsulotomy,” Journal of Cataract & Refractive Surgery, 2011 July; 37(7): 1189-1198
(3) Palanker, D., et al., “Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography,” Science Translational Medicine, Vol 2 Issue 58: 1-9 (2010)
(4) Dick, B. “The synergy of MICS and femtosecond lasers: the future of small incision cataract surgery,” Ophthalmology Times Europe, 2012 April; Vol 8 Issue 3
(5) Burkhard HD., “Femtosecond cataract surgery outcomes: an advance or not?” Proceedings from the XXX Congress of the European Society of Cataract and Refractive Surgery in Milan, Italy. September 2012.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10431426.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Liproxenol is First Diet Pill to Earn Perfect Score from Independent Review Organization
2. Dr. Steve Carstensen Presents First Webinar for Dental Division of American Sleep and Breathing Academy
3. First Choice Emergency Room Opens New Facility in Austin Arboretum
4. Director Neil Gonsalves to Perform A-lign CPAs First SSAE 16 Audit in India
5. First Choice Emergency Room Opens New Facility in Katy, Texas
6. 'LKLiveMapping' Improves Laboratory Operating Efficiency, Delivers a High First-Submission Approval of Claims, and Improves Collection
7. First-Born May Be at Greater Risk for Diabetes, Hypertension
8. Terris co-edits first textbook on thyroid surgery complications
9. Study drug is first to help patients with recurrent low-grade ovarian cancer
10. First anti-tuberculosis medicine under USAID-supported PQM program achieves WHO prequalification
11. Students in Educational First Steps Assisted Centers Show Persistent Benefits Far Beyond Early Childhood According to University of Texas at Dallas Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 2016 , ... W.S. Badger Co. Inc ., the maker of certified ... as one of the best small businesses for new dads by Fatherly, the digital ... businesses providing progressive benefits to new parents on the organization’s 2016 Best Places ...
(Date:5/27/2016)... ... May 27, 2016 , ... An educational campaign aimed at ... stories, courtesy of awareness-driven celebrities and thought leaders. It also provides insight to ... industry leaders such as Bioness. , As patients feel increasingly concerned about ...
(Date:5/27/2016)... ... 27, 2016 , ... Aimed at nurses and employees in the health care ... leaders in the nursing and health care industry. It also provides insight to the ... University. , As the nursing industry is coming out of one of the ...
(Date:5/26/2016)... ... , ... There are many ways to cook a hot dog, but new ... prefer their dogs straight off the grill. Of the 90 percent of Americans who ... cook a hot dog, far outpacing other cooking methods such as steaming (12 percent), ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... property (IP) to its specialty academic programs. , Answering to the increasing demand ... certificate programs in health law, and environmental and land use law. ,  , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25, 2016 MedDay, a ... announces that an oral presentation entitled "High doses of biotin ... trial" will be given by Professor Ayman Tourbah , ... Congress of the European Academy of Neurology (EAN) in ... related disorders 3" will take place on Sunday, 29 May ...
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und ... Überlegenheit in ‚ausgezeichneter plus guter ... Colons    ,      (Logo: ... gab heute neue positive Daten von der MORA-Studie ...
(Date:5/24/2016)... Celsion Corporation (NASDAQ: CLSN ... an update on its ongoing OVATION study, a ... the Company,s DNA-based immunotherapy, with the standard of ... advanced ovarian cancer who will undergo neoadjuvant chemotherapy ... IL-12 DNA plasmid vector formulated as a nanoparticle ...
Breaking Medicine Technology: